Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99213903 | 9921390 | 3 | F | 201402 | 20150924 | 20140225 | 20151001 | EXP | US-SA-2014SA022299 | AVENTIS | 63.00 | YR | A | F | Y | 110.00000 | KG | 20151001 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99213903 | 9921390 | 1 | PS | CEREZYME | IMIGLUCERASE | 1 | Intravenous drip | UNKNOWN | 20367 | 50.9 | MG/KG | POWDER FOR SOLUTION FOR INFUSION | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99213903 | 9921390 | 1 | Gaucher's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99213903 | 9921390 | HO |
| 99213903 | 9921390 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99213903 | 9921390 | Colon neoplasm | |
| 99213903 | 9921390 | Hospitalisation | |
| 99213903 | 9921390 | Ocular hyperaemia | |
| 99213903 | 9921390 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 99213903 | 9921390 | 1 | 20051017 | 0 |